Pre-Conference Workshops (am) & Main Conference Day 1 Plenary (pm)
Pre-Conference Workshops (am) & Main Conference Day 1 Plenary (pm)
Optional Pre-Conference Workshops
8:00am - 9:00am60 mins
Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
Registration and Coffee
8:00am - 9:00am60 mins
Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
Registration and Coffee
9:00am - 9:10am10 mins
Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
Workshop Moderator's Opening Remarks: Workshop #1
- Thomas Rupp - Owner & Principal, Thomas Rupp Consulting
9:00am - 9:10am10 mins
Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
Workshop Moderator's Opening Remarks: Workshop #2
- Bruce Morimoto, PhD - Independent Consultant, TIDES Advisor
9:10am - 9:55am45 mins
Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
Manufacturing and Upscale Challenges of Next-generation Oligonucleotide Therapeutics
- Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
9:10am - 9:55am45 mins
Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
Strategies for Manufacturing of Long and Complex Peptides: Technical Considerations and Case Studies
- Robert Hagopian - Global Director, Biotech Partnerships, PolyPeptide Group
- El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
9:55am - 10:40am45 mins
Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
Process-related Impurities of Next-generation Oligonucleotide Therapeutics
- Thomas Rupp - Owner & Principal, Thomas Rupp Consulting
9:55am - 10:35am40 mins
Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
Analytical Journey of a Peptide Therapeutic: A Tailored Approach
- Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
10:35am - 11:10am35 mins
Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
Networking Refreshment Break
10:40am - 11:15am35 mins
Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
Networking Refreshment Break
11:10am - 11:50am40 mins
Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
Innovations in Preparative Purification of Synthetic Peptides
- Marc Jacob, PhD - Head of Strategic Development, Chromatography Products, YMC America
11:15am - 12:00pm45 mins
Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
Phase- appropriate CMC Considerations for Next-generation Oligonucleotides
- Pablo Lores Lareo, PhD - CMC Director, Sylentis
11:50am - 12:30pm40 mins
Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
Synthesis Solutions Enabling Rapid Supply of Complex Cyclic Peptides
- Manabu Wadamoto, PhD - Chief Scientist, Chugai Pharmaceutical Co., Ltd.
12:00pm - 12:30pm30 mins
Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
Panel Discussion and Q&A with Workshop Speakers
12:30pm - 1:45pm75 mins
Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
Close of Workshop and Luncheon for Morning Workshop Attendees Only
12:30pm - 1:45pm75 mins
Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
Close of Workshop and Luncheon for Morning Workshop Attendees Only
1:45pm - 1:50pm5 mins
Main Conference Plenary Keynote Session
Chairperson’s Remarks: Keynote Day 1
1:50pm - 2:20pm30 mins
Main Conference Plenary Keynote Session
Development of New Molecular Technologies for siRNA Therapeutics
- Takeshi Wada, PhD - Professor of Organic Chemistry, Tokyo University of Science
2:20pm - 2:50pm30 mins
Main Conference Plenary Keynote Session
Thiomorpholino Oligonucleotides (TMOs) Useful for Exon Skipping, RNase H and siRNA Applications
- Marvin Caruthers, PhD - Distinguished Professor, Biochemistry, University of Colorado
2:50pm - 3:20pm30 mins
Main Conference Plenary Keynote Session
Latest Progress and Advances in RNAi Therapeutics
- Muthiah (Mano) Manoharan, PhD - Senior Vice President of Drug Innovation and Distinguished Research Scientist, Alnylam Pharmaceuticals
3:20pm - 4:00pm40 mins
Main Conference Plenary Keynote Session
Networking Refreshment Break
4:00pm - 4:30pm30 mins
Main Conference Plenary Keynote Session
Emerging Technologies in the Scale Up of Oligonucleotide Therapeutics
- Scott May, PhD - VP of Chemistry, Synthetic Molecule Design & Development, Eli Lilly and Company
4:30pm - 5:00pm30 mins
Main Conference Plenary Keynote Session
Clinical Development of Mazdutide, the First Dual GCG/GLP-1 Receptor Agonist Approval in China, for Chronic Weight Management
- Lei Qian, MD, PhD - Chief R&D Officer, General Biomedicine, Innoventbio
5:00pm - 5:30pm30 mins
Main Conference Plenary Keynote Session
The Science Behind the GLP-1 Medicines: A Historic View and Future Outlook
- Lotte Bjerre Knudsen, PhD - Chief Scientific Advisor & Head of GLP-1 CoE, Novo Nordisk A/S
5:30pm - 5:35pm5 mins
Main Conference Plenary Keynote Session
Close of Day One
* 活動內容有可能不事先告知作更動及調整。